CommonWell's 7 new members bring total to 40

The vendor-led association focused on interoperability in healthcare, the CommonWell Health Alliance, has increased its membership with seven new organizations.

New members include the following:

•    eClinicalWorks: A cloud-based EHR company (Westborough, Mass.)
•    HIMSS: A global nonprofit organization focused on health IT (Chicago)
•    ImageTrend: A web-based hospital and integrated health software provider (Lakeville, Minn.)
•    lifeIMAGE: An interoperable medical image sharing network  (Newton, Mass.)
•    Mana Health: A cloud platform-as-a-service designed to unify health data (New York)
•    MediPortal: A patient engagement solutions company (New York)
•    Modernizing Medicine: A specialty-specific provider of products and services

"We're thrilled to welcome eClinicalWorks, HIMSS, ImageTrend, lifeIMAGE, Mana Health, MediPortal and Modernizing Medicine to our growing organization," said Jitin Asnaani, executive director of CommonWell Health Alliance. "The diversity in our membership is representative of our commitment to reach the full continuum of care and to help ensure pertinent patient information is available to patients and caregivers regardless of where care occurred."

The alliance now has 40 members.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.